United States Biotechnology & Medical Research

Rezolute Inc (RZLT)

Track

Over the last 90 days, Rezolute Inc. has seen one insider transaction, a buy totaling $28,500 by the CFO. This activity represents a net buy of 0.00015% of the float. The company's stock has experienced a 5.1% price increase over the past 90 days, trading near its 52-week low.
Stock chart
Ticker: RZLT Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Evans Daron
CFO
1 purchase — total 28,500 USD
Buy 30 Mar 2026
Value US$3,789,802.04 | Price 498.27 | Shares 11,064
Buy 16 Dec 2025
Value US$155,935.23 | Price 136.67 | Shares 50,456
Buy 16 Dec 2025
Value US$47,600.00 | Price 1.70 | Shares 28,000
Buy 15 Dec 2025
Value US$160.00 | Price 1.60 | Shares 100
Buy 15 Dec 2025
Value US$19,438.80 | Price 1.62 | Shares 12,000
Buy 15 Dec 2025
Value US$50,880.00 | Price 1.59 | Shares 32,000
Buy 15 Dec 2025
Value US$4,475.00 | Price 1.79 | Shares 2,500
Buy 15 Dec 2025
Value US$4,462.50 | Price 1.79 | Shares 2,500
Buy 15 Dec 2025
Value US$70,640.00 | Price 1.77 | Shares 40,000
Buy 25 Jun 2025
Value US$10,939.00 | Price 4.38 | Shares 2,500
Buy 24 Jun 2025
Value US$20,250.00 | Price 4.05 | Shares 5,000
Buy 13 Jun 2025
Value US$3,999,999.25 | Price 3.25 | Shares 1,230,769
Buy 13 Jun 2025
Value US$9,997.00 | Price 3.25 | Shares 3,076
Buy 31 Mar 2025
Value US$19,733.36 | Price 2.92 | Shares 6,758
Buy 27 Mar 2025
Value US$34,999.19 | Price 2.85 | Shares 12,302
Buy 26 Mar 2025
Value US$28,800.00 | Price 2.88 | Shares 10,000
Buy 26 Mar 2025
Value US$28,900.00 | Price 2.89 | Shares 10,000
Buy 18 Feb 2025
Value US$47,000.00 | Price 4.70 | Shares 10,000
Buy 18 Dec 2024
Value US$42,900.00 | Price 4.29 | Shares 10,000
Buy 12 Dec 2024
Value US$41,400.00 | Price 4.60 | Shares 9,000
Buy 24 Sep 2024
Value US$20,017.30 | Price 4.70 | Shares 4,259
Buy 25 Jun 2024
Value US$5,000,000.00 | Price 4.00 | Shares 1,250,000
Buy 25 Jun 2024
Value US$19,982.25 | Price 4.15 | Shares 4,815
Buy 14 Jun 2024
Value US$1,190.97 | Price 3.97 | Shares 300
Buy 14 Jun 2024
Value US$11,724.60 | Price 3.91 | Shares 3,000
Buy 14 Jun 2024
Value US$1,188.00 | Price 3.96 | Shares 300
Buy 14 Jun 2024
Value US$15,639.60 | Price 3.91 | Shares 4,000
Buy 14 Jun 2024
Value US$161,568.00 | Price 4.04 | Shares 40,000
Buy 29 May 2024
Value US$1,578.50 | Price 3.50 | Shares 451
Buy 24 May 2024
Value US$9,502.66 | Price 3.23 | Shares 2,942
Buy 23 May 2024
Value US$165.30 | Price 2.85 | Shares 58
Buy 23 May 2024
Value US$16,057.80 | Price 2.68 | Shares 6,000
Buy 23 May 2024
Value US$4,080.00 | Price 2.72 | Shares 1,500
Buy 28 Mar 2024
Value US$1,275.00 | Price 2.55 | Shares 500
Buy 15 Mar 2024
Value US$33,830.00 | Price 1.69 | Shares 20,000
Buy 14 Mar 2024
Value US$18,800.00 | Price 1.88 | Shares 10,000
Buy 8 Mar 2024
Value US$96,345.00 | Price 1.93 | Shares 50,000
Buy 7 Mar 2024
Value US$69,859.44 | Price 1.91 | Shares 36,503
Buy 7 Mar 2024
Value US$925.00 | Price 1.85 | Shares 500
Buy 26 Feb 2024
Value US$8,400.00 | Price 1.68 | Shares 5,000
Buy 26 Feb 2024
Value US$3,400.00 | Price 1.70 | Shares 2,000
Buy 23 Feb 2024
Value US$10,140.00 | Price 1.69 | Shares 6,000
Buy 16 Feb 2024
Value US$9,142.00 | Price 1.31 | Shares 7,000
Buy 16 Feb 2024
Value US$6,165.00 | Price 1.37 | Shares 4,500
Buy 16 Feb 2024
Value US$6,165.00 | Price 1.37 | Shares 4,500
Buy 16 Feb 2024
Value US$54,411.34 | Price 1.30 | Shares 41,900
Buy 3 Jul 2023
Value US$9,499.50 | Price 1.90 | Shares 5,000
Buy 22 Jul 2022
Value US$12,000,001.00 | Price 3.80 | Shares 3,157,895
Buy 22 Jul 2022
Value US$299,998.60 | Price 3.80 | Shares 78,947
Buy 19 May 2022
Value US$883.77 | Price 2.95 | Shares 300
Buy 18 May 2022
Value US$571.98 | Price 2.86 | Shares 200
Buy 17 May 2022
Value US$3,406.50 | Price 3.41 | Shares 1,000
Buy 4 May 2022
Value US$95,000.00 | Price 3.80 | Shares 25,000
Buy 4 May 2022
Value US$79,997.60 | Price 3.80 | Shares 21,052
Buy 4 May 2022
Value US$199,997.80 | Price 3.80 | Shares 52,631
Buy 15 Oct 2021
Value US$5,000,001.50 | Price 6.50 | Shares 769,231
Buy 15 Oct 2021
Value US$50,004.50 | Price 6.50 | Shares 7,693
Planned buy 13 Oct 2020
Value US$58,380.50 | Price 23.35 | Shares 2,500
Planned buy 12 Oct 2020
Value US$58,112.50 | Price 0.46 | Shares 125,000
Planned buy 7 Oct 2020
Value US$50,925.00 | Price 0.41 | Shares 125,000
Planned buy 6 Oct 2020
Value US$52,900.00 | Price 0.42 | Shares 125,000
Planned buy 5 Oct 2020
Value US$57,175.00 | Price 0.46 | Shares 125,000
Planned buy 2 Oct 2020
Value US$56,362.50 | Price 0.45 | Shares 125,000
Planned buy 1 Oct 2020
Value US$55,037.50 | Price 0.44 | Shares 125,000
Planned buy 30 Sep 2020
Value US$54,537.50 | Price 0.44 | Shares 125,000
Planned buy 25 Sep 2020
Value US$55,737.50 | Price 0.45 | Shares 125,000
Planned buy 24 Sep 2020
Value US$55,400.00 | Price 0.44 | Shares 125,000
Planned buy 23 Sep 2020
Value US$57,137.50 | Price 0.46 | Shares 125,000
Planned buy 22 Sep 2020
Value US$57,362.50 | Price 0.46 | Shares 125,000
Planned buy 21 Sep 2020
Value US$57,362.50 | Price 0.46 | Shares 125,000
Planned buy 18 Sep 2020
Value US$57,562.50 | Price 0.46 | Shares 125,000
Planned buy 17 Sep 2020
Value US$57,712.50 | Price 0.46 | Shares 125,000
Planned buy 16 Sep 2020
Value US$57,162.50 | Price 0.46 | Shares 125,000
Planned buy 15 Sep 2020
Value US$56,412.50 | Price 0.45 | Shares 125,000
Planned buy 14 Sep 2020
Value US$57,550.00 | Price 0.46 | Shares 125,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-31 2026-03-30 B Purchase
4.3
Evans Daron

CFO

Officer
11,064 +46.9%
498.27
US$3,789,802 		11,064 +46.9% 498.27 US$3,789,802
2025-12-17 2025-12-16 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
50,456 -13.1%
136.67
US$155,935 		50,456 -13.1% 136.67 US$155,935
2025-12-17 2025-12-16 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
11,355 +23.2%
19.83
US$4,991,875 		11,355 +23.2% 19.83 US$4,991,875
2025-12-15 2025-12-15 B Purchase
3.4
Karnawat Sunil Ratilal

Chief Commercial Officer

Officer
100 +0.1%
1.60
US$160 		100 +0.1% 1.60 US$160
2025-12-15 2025-12-15 B Purchase
3.4
Karnawat Sunil Ratilal

Chief Commercial Officer

Officer
12,000 +20.2%
1.62
US$19,439 		12,000 +20.2% 1.62 US$19,439
2025-12-15 2025-12-15 B Purchase
3.3
Elam Nevan C

CEO

Executive Director
32,000 +5.3%
1.59
US$50,880 		32,000 +5.3% 1.59 US$50,880
2025-12-15 2025-12-15 B Purchase
4.3
Evans Daron

CFO

Officer
2,500 +55.6%
1.79
US$4,475 		2,500 +55.6% 1.79 US$4,475
2025-12-15 2025-12-15 B Purchase
4.3
Evans Daron

CFO

Officer
2,500 +55.6%
1.79
US$4,462 		2,500 +55.6% 1.79 US$4,462
2025-12-15 2025-12-15 B Purchase
4.3
Evans Daron

CFO

Officer
40,000 +10.6%
1.77
US$70,640 		40,000 +10.6% 1.77 US$70,640
2025-06-26 2025-06-25 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
2,500 +19.2%
4.38
US$10,939 		2,500 +19.2% 4.38 US$10,939
2025-06-24 2025-06-24 B Purchase
4.3
Evans Daron

CFO

Officer
5,000 +1.9%
4.05
US$20,250 		5,000 +1.9% 4.05 US$20,250
2025-06-23 2025-06-13 B Purchase
3.7
Kim Young-Jin
Non-Executive Director
1,230,769 +17.1%
3.25
US$3,999,999 		1,230,769 +17.1% 3.25 US$3,999,999
2025-06-23 2025-06-13 B Purchase
KREHER NERISSA
Non-Executive Director
3,076 +8.9%
3.25
US$9,997 		3,076 +8.9% 3.25 US$9,997
2025-04-01 2025-03-31 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
6,758 +8.7%
2.92
US$19,733 		6,758 +8.7% 2.92 US$19,733
2025-03-31 2025-03-27 B Purchase
3.3
Elam Nevan C

CEO

Executive Director
12,302 +5.8%
2.85
US$34,999 		12,302 +5.8% 2.85 US$34,999
2025-03-28 2025-03-26 B Purchase
4.3
Evans Daron

CFO

Officer
10,000 +76.9%
2.88
US$28,800 		10,000 +76.9% 2.88 US$28,800
2025-03-28 2025-03-26 B Purchase
4.3
Evans Daron

CFO

Officer
10,000 +4.4%
2.89
US$28,900 		10,000 +4.4% 2.89 US$28,900
2025-02-20 2025-02-18 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
10,000 +14.9%
4.70
US$47,000 		10,000 +14.9% 4.70 US$47,000
2024-12-18 2024-12-18 B Purchase
4.3
Evans Daron

CFO

Officer
10,000 +7.1%
4.29
US$42,900 		10,000 +7.1% 4.29 US$42,900
2024-12-12 2024-12-12 B Purchase
4.3
Evans Daron

CFO

Officer
9,000 +6.8%
4.60
US$41,400 		9,000 +6.8% 4.60 US$41,400
2024-09-24 2024-09-24 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
4,259 +11.4%
4.70
US$20,017 		4,259 +11.4% 4.70 US$20,017
2025-02-19 2024-06-25 B Purchase
3.7
Kim Young-Jin
Non-Executive Director
1,250,000 +21.0%
4.00
US$5,000,000 		1,250,000 +21.0% 4.00 US$5,000,000
2024-06-27 2024-06-25 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
4,815 +14.7%
4.15
US$19,982 		4,815 +14.7% 4.15 US$19,982
2024-06-14 2024-06-14 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
300 +27.9%
3.97
US$1,191 		300 +27.9% 3.97 US$1,191
2024-06-14 2024-06-14 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
3,000 +30.0%
3.91
US$11,725 		3,000 +30.0% 3.91 US$11,725
2024-06-14 2024-06-14 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
300 +0.6%
3.96
US$1,188 		300 +0.6% 3.96 US$1,188
2024-06-14 2024-06-14 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
4,000 +8.0%
3.91
US$15,640 		4,000 +8.0% 3.91 US$15,640
2024-06-14 2024-06-14 B Purchase
4.3
Evans Daron

CFO

Officer
40,000 +inf%
4.04
US$161,568 		40,000 +inf% 4.04 US$161,568
2024-05-31 2024-05-29 B Purchase
4.3
Evans Daron

CFO

Officer
451 +0.4%
3.50
US$1,578 		451 +0.4% 3.50 US$1,578
2024-05-28 2024-05-24 B Purchase
4.3
Evans Daron

CFO

Officer
2,942 +29.3%
3.23
US$9,503 		2,942 +29.3% 3.23 US$9,503
2024-05-28 2024-05-23 B Purchase
4.3
Evans Daron

CFO

Officer
58 +0.6%
2.85
US$165 		58 +0.6% 2.85 US$165
2024-05-28 2024-05-23 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
6,000 +13.6%
2.68
US$16,058 		6,000 +13.6% 2.68 US$16,058
2024-05-28 2024-05-23 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
1,500 +3.5%
2.72
US$4,080 		1,500 +3.5% 2.72 US$4,080
2024-03-29 2024-03-28 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
500 +86.8%
2.55
US$1,275 		500 +86.8% 2.55 US$1,275
2024-03-19 2024-03-15 B Purchase
4.3
Evans Daron

CFO

Officer
20,000 +inf%
1.69
US$33,830 		20,000 +inf% 1.69 US$33,830
2024-03-18 2024-03-14 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
10,000 +inf%
1.88
US$18,800 		10,000 +inf% 1.88 US$18,800
2024-03-08 2024-03-08 B Purchase
4.3
Evans Daron

CFO

Officer
50,000 +70.5%
1.93
US$96,345 		50,000 +70.5% 1.93 US$96,345
2024-03-14 2024-03-07 B Purchase
3.7
Kim Young-Jin
Non-Executive Director
36,503 +46.2%
1.91
US$69,859 		36,503 +46.2% 1.91 US$69,859
2024-03-11 2024-03-07 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
500 +inf%
1.85
US$925 		500 +inf% 1.85 US$925
2024-02-28 2024-02-26 B Purchase
3.3
Elam Nevan C

CEO

Executive Director
5,000 +177.5%
1.68
US$8,400 		5,000 +177.5% 1.68 US$8,400
2024-02-27 2024-02-26 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
2,000 +4.9%
1.70
US$3,400 		2,000 +4.9% 1.70 US$3,400
2024-02-27 2024-02-23 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
6,000 +17.4%
1.69
US$10,140 		6,000 +17.4% 1.69 US$10,140
2024-02-21 2024-02-16 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
7,000 +25.4%
1.31
US$9,142 		7,000 +25.4% 1.31 US$9,142
2024-02-20 2024-02-16 B Purchase
4.3
Evans Daron

CFO

Officer
4,500 +inf%
1.37
US$6,165 		4,500 +inf% 1.37 US$6,165
2024-02-20 2024-02-16 B Purchase
4.3
Evans Daron

CFO

Officer
4,500 +inf%
1.37
US$6,165 		4,500 +inf% 1.37 US$6,165
2024-02-20 2024-02-16 B Purchase
4.3
Evans Daron

CFO

Officer
41,900 +144.5%
1.30
US$54,411 		41,900 +144.5% 1.30 US$54,411
2023-07-06 2023-07-03 B Purchase
4.0
ROBERTS BRIAN KENNETH

Chief Medical Officer

Officer
5,000 +22.2%
1.90
US$9,500 		5,000 +22.2% 1.90 US$9,500
2024-03-19 2022-07-22 B Purchase
0.6
HANDOK, INC.
Non-Executive Director Large shareholder
3,157,895 +113.4%
3.80
US$12,000,001 		3,157,895 +113.4% 3.80 US$12,000,001
2024-03-14 2022-07-22 B Purchase
3.7
Kim Young-Jin
Non-Executive Director
78,947 +inf%
3.80
US$299,999 		78,947 +inf% 3.80 US$299,999
2022-05-19 2022-05-19 B Purchase
4.0
ROBERTS BRIAN KENNETH

Sr VP, Clinic Development

Officer
300 +1.3%
2.95
US$884 		300 +1.3% 2.95 US$884
2022-05-19 2022-05-18 B Purchase
4.0
ROBERTS BRIAN KENNETH

Sr VP, Clinic Development

Officer
200 +0.9%
2.86
US$572 		200 +0.9% 2.86 US$572
2022-05-19 2022-05-17 B Purchase
4.0
ROBERTS BRIAN KENNETH

Sr VP, Clinic Development

Officer
1,000 +4.8%
3.41
US$3,406 		1,000 +4.8% 3.41 US$3,406
2022-05-06 2022-05-04 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
25,000 +325.0%
3.80
US$95,000 		25,000 +325.0% 3.80 US$95,000
2022-05-06 2022-05-04 B Purchase
4.0
ROBERTS BRIAN KENNETH

Sr VP, Clinic Development

Officer
21,052 +inf%
3.80
US$79,998 		21,052 +inf% 3.80 US$79,998
2022-05-06 2022-05-04 B Purchase
3.6
Labrucherie Gil M
Non-Executive Director
52,631 +inf%
3.80
US$199,998 		52,631 +inf% 3.80 US$199,998
2024-03-19 2021-10-15 B Purchase
0.6
HANDOK, INC.
Non-Executive Director Large shareholder
769,231 +38.2%
6.50
US$5,000,002 		769,231 +38.2% 6.50 US$5,000,002
2022-05-06 2021-10-15 B Purchase
2.3
Hogenhuis Wladimir
Non-Executive Director
7,693 +inf%
6.50
US$50,004 		7,693 +inf% 6.50 US$50,004
2020-10-14 2020-10-13 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
2,500 +0.1%
23.35
US$58,380 		2,500 +0.1% 23.35 US$58,380
2020-10-14 2020-10-12 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$58,112 		125,000 +0.1% 0.46 US$58,112
2020-10-08 2020-10-07 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.41
US$50,925 		125,000 +0.1% 0.41 US$50,925
2020-10-07 2020-10-06 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.42
US$52,900 		125,000 +0.1% 0.42 US$52,900
2020-10-07 2020-10-05 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,175 		125,000 +0.1% 0.46 US$57,175
2020-10-05 2020-10-02 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.45
US$56,362 		125,000 +0.1% 0.45 US$56,362
2020-10-02 2020-10-01 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.44
US$55,038 		125,000 +0.1% 0.44 US$55,038
2020-10-02 2020-09-30 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.44
US$54,538 		125,000 +0.1% 0.44 US$54,538
2020-09-28 2020-09-25 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.45
US$55,738 		125,000 +0.1% 0.45 US$55,738
2020-09-25 2020-09-24 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.44
US$55,400 		125,000 +0.1% 0.44 US$55,400
2020-09-25 2020-09-23 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,138 		125,000 +0.1% 0.46 US$57,138
2020-09-23 2020-09-22 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,362 		125,000 +0.1% 0.46 US$57,362
2020-09-23 2020-09-21 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,362 		125,000 +0.1% 0.46 US$57,362
2020-09-21 2020-09-18 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,562 		125,000 +0.1% 0.46 US$57,562
2020-09-18 2020-09-17 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,712 		125,000 +0.1% 0.46 US$57,712
2020-09-18 2020-09-16 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,162 		125,000 +0.1% 0.46 US$57,162
2020-09-16 2020-09-15 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.45
US$56,412 		125,000 +0.1% 0.45 US$56,412
2020-09-16 2020-09-14 PP Planned purchase
0.6
HANDOK, INC.
Large shareholder
125,000 +0.1%
0.46
US$57,550 		125,000 +0.1% 0.46 US$57,550
Explore more

More insider trading research around Rezolute Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America